HeartCore Reports Second Quarter 2026 Financial Results

Rhea-AI Summary

HeartCore (Nasdaq: HTCR) reported second quarter 2026 revenue of $321,000, up 71.6% year-over-year, driven mainly by higher software development services from its HeartCore Luvina subsidiary, partially offset by lower Go IPO consulting revenue. Q2 gross loss widened to $70,000, and net loss was $2.0 million versus net income of $1.1 million a year earlier. Adjusted EBITDA for Q2 was $(1.3) million, compared with $(0.1) million.

For the first six months of 2026, revenue rose 25.9% to $553,926, but the Company recorded a net loss of $4.0 million and Adjusted EBITDA of $(2.9) million. HeartCore completed the divestiture of Sigmaways and agreed to sell its 51% stake in HeartCore Luvina, sharpening focus on Go IPO consulting and financial services. As of June 30, 2026, cash and cash equivalents were $587,074, with total assets of $8.9 million, and the Company had regained compliance with Nasdaq’s $1.00 minimum bid price requirement.

Positive

• Q2 2026 revenue up 71.6% year-over-year to $321,000
• Six‑month 2026 revenue up 25.9% year-over-year to $553,926
• Completed Sigmaways divestiture, exiting a non-core business line
• Agreement to sell 51% stake in HeartCore Luvina to Luvina Software
• Regained Nasdaq $1.00 bid price compliance under Listing Rule 5550(a)(2)

Negative

• Q2 2026 net loss of $2.0 million versus $1.1 million net income
• Six‑month 2026 net loss widened to $4.0 million from $2.1 million
• Q2 Adjusted EBITDA declined to $(1.3) million from $(0.1) million
• Cash and cash equivalents fell to $587,074 from $1,904,826 at December 31, 2025
• Total assets decreased to $8.9 million from $13.1 million year-end 2025
• Loss from discontinued operations of $732,723 versus prior-year income of $655,084

News Explained

HeartCore reported 1,441,565 common shares and $587,074 cash at June 30, adding ownership and liquidity detail to the results.

HeartCore's June 30, 2026 balance sheet reports 1,441,565 common shares outstanding, versus 1,270,991 on December 31, 2025.

A higher total share count reduces an existing holder's percentage ownership if it reflects additional shares and there are no offsetting changes. The balance sheet also reports 617 Series A convertible preferred shares outstanding and an aggregate liquidation preference of $748,228.

For liquidity context, cash and equivalents were $774,033 at March 31, 2026, equal to 60.4 days of that quarter's operating cash use, while the release reports $587,074 at June 30, 2026.

Sources and calculations

• HeartCore Reports Second Quarter 2026 Financial Results (2026-08-13)
• Dilution (undated)
• HeartCore Q1 2026 fundamentals (2026-03-31)

• Cash and equivalents vs quarterly operating cash outflow, in days of cash use $774,033 / ($1,153,590 / 90) = [object Object]

Market Context

The platform record identifies 1058417 as the prior earnings event, while short positioning was cate...

Analysis

The platform record identifies 1058417 as the prior earnings event, while short positioning was categorized as low. This release adds revenue growth alongside larger losses; cash resources and discontinued operations remain items to monitor.

Key Figures

Q2 Revenue: $321,000, up 71.6% Q2 Gross Loss: $70,000 Q2 Net Loss: $2.0 million +5 more

8 metrics

Q2 Revenue $321,000, up 71.6% Second quarter 2026 vs. $187,000 prior-year period

Q2 Gross Loss $70,000 Second quarter 2026 vs. $23,000 gross loss prior year

Q2 Net Loss $2.0 million Second quarter 2026 vs. $1.1 million net income prior year

Q2 Adjusted EBITDA $(1.3) million Second quarter 2026 vs. $(0.1) million prior year

Six-Month Revenue $554,000, up 25.9% Six months ended June 30, 2026 vs. $440,000 prior year

Six-Month Net Loss $4.0 million Six months ended June 30, 2026 vs. $2.1 million prior-year loss

Cash and Equivalents $587,000 As of June 30, 2026

Go IPO Clients 16 clients, including 6 in preparation As of June 30, 2026

Previous Earnings Reports

5 past events · Latest: May 15 (Negative)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 15	1Q26 earnings	Negative	-3.3%	Lower revenue and EBITDA loss accompanied a narrower net loss.
Mar 31	FY25 earnings	Positive	-26.1%	Reported net income and strategic divestiture gains despite sharply lower revenue.
Feb 11	FY25 preliminary results	Positive	-1.7%	Projected revenue and net income ranges following the software subsidiary divestiture.
Nov 18	3Q25 earnings	Negative	-18.7%	Revenue declined substantially while the software subsidiary became discontinued operations.
Aug 13	2Q25 earnings	Positive	+8.1%	Revenue, gross profit, and net income improved year over year.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings-tagged events averaged a -8.36% reaction, with three aligned negative reactions and two divergences.

Key Terms

adjusted ebitda, discontinued operations, non-gaap financial measure, gaap

4 terms

adjusted ebitda financial

"Adjusted EBITDA was $(1.3) million for the second quarter of 2026"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

discontinued operations financial

"a loss from discontinued operations"

Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.

non-gaap financial measure financial

"Adjusted EBITDA, which is a non-GAAP financial measure"

A non-GAAP financial measure is a way companies present their financial results that excludes certain expenses or income to show how they believe their core business is performing. It matters because it can give a clearer picture of how the company is really doing, but it can also be used to make results look better than they actually are.

gaap financial

"financial information prepared and presented in accordance with GAAP"

GAAP, or Generally Accepted Accounting Principles, are a set of standardized rules and guidelines that companies follow when preparing their financial statements. They ensure consistency, transparency, and comparability across different companies, making it easier for investors to understand and compare financial information accurately. This helps investors make informed decisions based on trustworthy and uniform financial reports.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK and TOKYO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the second quarter ended June 30, 2026.

Recent Operational Highlights

• As of June 30, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential initial public offerings and U.S. exchange listings.
• Entered into an agreement with Luvina Software Joint Stock Company to divest the Company’s 51% equity interest in HeartCore Luvina Vietnam Company Limited (“HeartCore Luvina”) as part of ongoing portfolio optimization.
• Completed the strategic divestiture of Sigmaways, Inc. (“Sigmaways”), concentrating the Company’s business on Go IPO consulting, capital markets advisory, and financial services.
• Regained compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
  
  

Management Commentary
HeartCore CEO Sumitaka Kanno commented: “During the first half of 2026, we took decisive steps to simplify HeartCore’s operating structure and sharpen our strategic focus. The divestiture of Sigmaways and the pending disposition of our 51% equity interest in HeartCore Luvina Vietnam represent important components of our ongoing portfolio optimization and will allow us to further concentrate resources on our core Go IPO and planned launch of our financial services business. The Nasdaq listing environment remains selective and compliance-driven, reinforcing the importance of disciplined client selection and thorough preparation. Accordingly, we are prioritizing opportunities with clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path toward satisfying U.S. regulatory and exchange-listing requirements. With a streamlined portfolio and a more focused pipeline, we believe HeartCore is better positioned to deepen client relationships and advance its capital markets and financial services initiatives.”

Second Quarter 2026 Financial Results
Revenues increased by 71.6% to $321,000, compared to $187,000 in the same period last year. The increase was primarily due to an increase in software development services revenue in connection with additional customer orders obtained by HeartCore Luvina, the Company’s Vietnamese subsidiary, partially offset by a decrease in Go IPO consulting services revenue primarily due to fewer Go IPO customers and extensions of IPO timelines by IPO customers during the current period.

Gross loss was $70,000, compared to gross loss of $23,000 in the same period last year. The increase in gross loss was primarily due to a decrease in gross profit from Go IPO consulting services, as the Company devoted additional efforts and resources, and incurred more outsourcing expenses, to enhance its Go IPO consulting customer experience, partially offset by an increase in gross profit from software development services in light of the increase in sales.

Operating expenses were $754,000, compared to $745,000 in the same period last year. The increase was primarily due to an increase in general and administrative expenses, partially offset by a decrease in selling expenses.

Net loss was $2.0 million, compared to net income of $1.1 million in the same period last year, as a result of the aforementioned increase in gross loss, a shift from other income to other expenses, and a loss from discontinued operations.

Adjusted EBITDA was $(1.3) million for the second quarter of 2026, compared to Adjusted EBITDA of $(0.1) million in the same period last year.

Six Months Ended June 30, 2026 Financial Results
Revenues increased by 25.9% to $554,000 for the first six months of 2026, compared to $440,000 in the same period last year. The increase was primarily due to an increase in software development services revenue in connection with additional customer orders obtained by HeartCore Luvina, partially offset by a decrease in Go IPO consulting services revenue primarily due to fewer Go IPO customers and extensions of IPO timelines by IPO customers during the current period.

Gross loss was $178,000, compared to gross profit of $75,000 in the same period last year. The decline in gross profit was primarily due to a decrease in gross profit from Go IPO consulting services, as the Company devoted additional efforts and resources to enhance its Go IPO consulting customer experience, resulting in a gross loss from Go IPO consulting services, partially offset by an increase in gross profit from software development services in light of the increase in sales.

Operating expenses were $2.0 million, compared to $1.9 million in the same period last year. The increase was primarily due to an increase in general and administrative expenses, partially offset by a decrease in selling expenses.

Net loss was $4.0 million, compared to a net loss of $2.1 million in the same period last year, as a result of the aforementioned decrease in gross profit, an increase in other expenses, and a loss from discontinued operations.

Adjusted EBITDA was $(2.9) million for the six months ended June 30, 2026, compared to Adjusted EBITDA of $(1.2) million in the same period last year.

As of June 30, 2026, the Company had cash and cash equivalents of $587,000.

About HeartCore Enterprises, Inc.
HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.

Non-GAAP Financial Measures
This document includes references to Adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, Adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, changes in fair value of derivative liability, interest income, interest expenses, other income, and other expenses.

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

Management believes that Adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

For the six months ended June 30,

Item	2026	2025
Net loss	($4.0) million	($2.1) million
(+) Depreciation	$0.0 million	$0.0 million
(+) Changes in fair value of investments in marketable securities	$0.8 million	$0.9 million
(+) Changes in fair value of investment in warrants	$0.0 million	($0.1) million
(+) Changes in fair value of derivative liability	($0.0) million	$0.0 million
(+) Interest income	($0.0) million	($0.0) million
(+) Interest expenses	$0.0 million	$0.0 million
(+) Other income	($0.0) million	($0.0) million
(+) Other expenses	$0.3 million	$0.0 million
Adjusted EBITDA	($2.9) million	($1.2) million

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore Investor Relations Contact:
Gateway Group, Inc.
John Yi and Steven Shinmachi
HTCR@gateway-grp.com 
(949) 574-3860

	HEARTCORE ENTERPRISES, INC.
	CONSOLIDATED BALANCE SHEETS
			June 30,			December 31,
			2026			2025
			(Unaudited)
	ASSETS
	Current assets:
	Cash and cash equivalents	$	587,074		$	1,904,826
	Accounts receivable		62,770			22,830
	Investments in marketable securities		2,668,317			3,690,187
	Prepaid expenses		114,340			127,565
	Deferred offering costs		250,000			250,000
	Other current assets		113,670			208,503
	Current assets of discontinued operations		-			920,683
	Proceeds receivable from sale of discontinued operations		467,970			1,291,298
	Total current assets		4,264,141			8,415,892
	Non-current assets:
	Property and equipment, net		252,389			275,465
	Operating lease right-of-use assets		412,976			17,781
	Long-term investment in warrants		121,774			280,924
	Deferred tax assets		22,286			23,121
	Security deposits		270,525			281,313
	Other non-current assets		816			549
	Non-current assets of discontinued operations		-			29,437
	Long-term proceeds receivable from sale of discontinued operations		3,520,918			3,736,995
	Total non-current assets		4,601,684			4,645,585
	Total assets	$	8,865,825		$	13,061,477
	LIABILITIES AND SHAREHOLDERS' EQUITY
	Current liabilities:
	Accounts payable and accrued expenses	$	286,711		$	299,042
	Accounts payable and accrued expenses - related party		33,946			124,618
	Accrued payroll and other employee costs		88,057			64,203
	Due to related party		460			285
	Insurance premium financing		66,327			13,430
	Operating lease liabilities, current		280,326			17,781
	Income tax payables		1,737,804			1,857,386
	Deferred revenue		568,773			676,216
	Derivative liability		74,461			121,719
	Other current liabilities		523,236			526,984
	Current liabilities of discontinued operations		-			1,628,586
	Total current liabilities		3,660,101			5,330,250
	Non-current liabilities:
	Operating lease liabilities, non-current		139,094			-
	Non-current liabilities of discontinued operations		-			448,376
	Total non-current liabilities		139,094			448,376
	Total liabilities		3,799,195			5,778,626
	Shareholders' equity:
	Preferred shares, $0.0001 par value, 20,000,000 shares authorized; Series A convertible preferred shares, 4,000 shares designated, 617 and 1,017 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; aggregate liquidation preference of $748,228 and $1,158,362 as of June 30, 2026 and December 31, 2025, respectively		419,741			691,858
	Common shares, $0.0001 par value, 200,000,000 shares authorized, 1,441,565 and 1,270,991 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively*		144			127
	Additional paid-in capital		22,128,976			21,902,169
	Accumulated deficit		(17,650,321	)		(13,755,534	)
	Accumulated other comprehensive loss		(2,702	)		(58,497	)
	Total HeartCore Enterprises, Inc. shareholders' equity		4,895,838			8,780,123
	Non-controlling interests		170,792			(1,497,272	)
	Total shareholders' equity		5,066,630			7,282,851
	Total liabilities and shareholders' equity	$	8,865,825		$	13,061,477

	HEARTCORE ENTERPRISES, INC.
	UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
			For the Six Months
			Ended June 30,
			2026			2025
	Revenues	$	553,926		$	439,909
	Cost of revenues (including cost of revenues resulting from transactions with a related party of $151,143 and $265,678 for the three and six months ended June 30, 2026, respectively, and of $31,328 and $56,523 for the three and six months ended June 30, 2025, respectively)		732,056			365,142
	Gross profit (loss)		(178,130	)		74,767
	Operating expenses:
	Selling expenses		69,203			214,596
	General and administrative expenses (including general and administrative expenses resulting from transactions with a related party of nil for the three and six months ended June 30, 2026, and of $11,433 and $29,048 for the three and six months ended June 30, 2025, respectively)		1,888,888			1,708,906
	Total operating expenses		1,958,091			1,923,502
	Loss from continuing operations		(2,136,221	)		(1,848,735	)
	Other income (expenses):
	Changes in fair value of investments in marketable securities		(817,491	)		(928,955	)
	Changes in fair value of investment in warrants		(16,635	)		72,660
	Changes in fair value of derivative liability		47,258			-
	Interest income		601			3,444
	Interest expenses		(4,477	)		(5,874	)
	Other income		31,181			22,995
	Other expenses		(349,386	)		(913	)
	Total other income (expenses)		(1,108,949	)		(836,643	)
	Income (loss) from continuing operations before income tax expense		(3,245,170	)		(2,685,378	)
	Income tax expense		38,341			45,581
	Net income (loss) from continuing operations		(3,283,511	)		(2,730,959	)
	Income (loss) from discontinued operations, net of income tax		(732,723	)		655,084
	Net income (loss)		(4,016,234	)		(2,075,875	)
	Less: net income from continuing operations attributable to non-controlling interests		30,074			18,888
	Less: loss from discontinued operations attributable to non-controlling interests		(151,521	)		(107,673	)
	Net income (loss) attributable to HeartCore Enterprises, Inc.		(3,894,787	)		(1,987,090	)
	Dividends accrued on Series A convertible preferred shares		(47,324	)		(611	)
	Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders	$	(3,942,111	)	$	(1,987,701	)
	Other comprehensive income (loss):
	Foreign currency translation adjustment		(34,513	)		48,038
	Total comprehensive income (loss)		(4,050,747	)		(2,027,837	)
	Less: comprehensive loss attributable to non-controlling interests		(130,384	)		(89,935	)
	Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.	$	(3,920,363	)	$	(1,937,902	)
	Net income (loss) from continuing operations attributable to HeartCore Enterprises, Inc. per common share*
	Basic	$	(2.51	)	$	(2.49	)
	Diluted	$	(2.51	)	$	(2.49	)
	Income (loss) from discontinued operations per common share*
	Basic	$	(0.43	)	$	0.69
	Diluted	$	(0.43	)	$	0.69
	Net income (loss) attributable to HeartCore Enterprises, Inc. per common share*
	Basic	$	(2.94	)	$	(1.80	)
	Diluted	$	(2.94	)	$	(1.80	)
	Weighted average common shares outstanding*
	Basic		1,341,297			1,103,617
	Diluted		1,341,297			1,105,245

	HEARTCORE ENTERPRISES, INC.
	UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
			For the Six Months
			Ended June 30,
			2026			2025
	Cash flows from operating activities of continuing operations:
	Net loss	$	(4,016,234	)	$	(2,075,875	)
	Income (loss) from discontinued operations, net of income tax		(732,723	)		655,084
	Net loss from continuing operations		(3,283,511	)		(2,730,959	)
	Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations:
	Depreciation expense		15,394			28,728
	Loss on disposal of property and equipment		-			116,981
	Non-cash lease expense		133,553			30,620
	Gain on termination of lease		-			(9,059	)
	Deferred income taxes		-			27,673
	Stock-based compensation		2,031			60,204
	Changes in fair value of investments in marketable securities		817,491			928,955
	Changes in fair value of investment in warrants		16,635			(72,660	)
	Changes in fair value of derivative liability		(47,258	)		-
	Gain on settlement of asset retirement obligations		-			(45,873	)
	Changes in assets and liabilities:
	Accounts receivable		(40,102	)		(30,439	)
	Prepaid expenses		120,260			60,557
	Other assets		83,271			152,927
	Accounts payable and accrued expenses		(9,464	)		(106,918	)
	Accounts payable and accrued expenses - related party		(90,717	)		(23,386	)
	Accrued payroll and other employee costs		25,945			(35,053	)
	Due to related party		191			(884	)
	Operating lease liabilities		(126,904	)		(23,648	)
	Income tax payables		11,150			(105,946	)
	Deferred revenue		(107,443	)		(190,163	)
	Other liabilities		(3,278	)		2,865
	Net cash flows used in operating activities of continuing operations		(2,482,756	)		(1,965,478	)
	Cash flows from investing activities of continuing operations:
	Purchases of property and equipment		(1,840	)		-
	Proceeds from sale of marketable securities		346,894			1,071,732
	Net cash flows provided by investing activities of continuing operations		345,054			1,071,732
	Cash flows from financing activities of continuing operations:
	Payments for finance lease		-			(8,375	)
	Repayment of insurance premium financing		(55,103	)		(65,257	)
	Proceeds from issuance of common shares related to at the market offering agreement		-			30,445
	Proceeds from collection of subscription receivable		-			103,942
	Proceeds from exercise of stock options		-			117,000
	Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs		-			1,800,000
	Net cash flows provided by (used in) financing activities of continuing operations		(55,103	)		1,977,755
	Cash flows from discontinued operations:
	Net cash flows used in operating activities of discontinued operations		(11,397	)		(709,414	)
	Net cash flows provided by investing activities of discontinued operations		844,198			19,904
	Net cash flows used in financing activities of discontinued operations		(22,134	)		(206,988	)
	Net cash flows provided by (used in) discontinued operations		810,667			(896,498	)
	Effect of exchange rate changes		(16,750	)		39,022
	Net change in cash and cash equivalents		(1,398,888	)		226,533
	Cash and cash equivalents - beginning of the period		1,985,962			2,121,089
	Cash and cash equivalents - end of the period	$	587,074		$	2,347,622
	Supplemental cash flow disclosures:
	Interest paid	$	30,674		$	63,320
	Income taxes paid (received), net	$	(17,394	)	$	131,118
	Non-cash investing and financing transactions:
	Insurance premium financing	$	108,000		$	139,500
	Warrants converted to marketable securities	$	142,515		$	-
	Operating lease right-of-use assets obtained in exchange for operating lease liabilities	$	552,577		$	23,495
	Dividends accrued on Series A convertible preferred shares	$	47,324		$	611
	Series A convertible preferred shares converted to common shares	$	272,117		$	-
	Issuance of common shares related to equity purchase agreement	$	-		$	250,000

FAQ

How did HeartCore (HTCR) perform financially in Q2 2026?

HeartCore reported Q2 2026 revenue of $321,000, a 71.6% year-over-year increase. According to the company, this was mainly driven by higher software development services, while lower Go IPO consulting revenue and higher costs led to a $2.0 million net loss.

What were HeartCore (HTCR) results for the six months ended June 30, 2026?

For the first half of 2026, HeartCore generated $553,926 in revenue, up 25.9% year-over-year. According to the company, it recorded a net loss of $4.0 million and Adjusted EBITDA of $(2.9) million, reflecting weaker gross profit and higher other expenses.

Why did HeartCore’s net income turn to a loss in Q2 2026?

HeartCore’s Q2 2026 net result shifted to a $2.0 million loss from $1.1 million income a year earlier. According to the company, drivers included higher gross loss, a move from other income to other expenses, and a loss from discontinued operations.

What strategic divestitures did HeartCore (HTCR) announce in 2026?

In 2026, HeartCore completed the divestiture of Sigmaways and agreed to sell its 51% equity interest in HeartCore Luvina. According to the company, these actions support portfolio optimization and refocus resources on Go IPO consulting and planned financial services.

What is HeartCore’s cash position and balance sheet as of June 30, 2026?

As of June 30, 2026, HeartCore had $587,074 in cash and cash equivalents and total assets of $8.9 million. According to the company, total current assets were $4.3 million, and total shareholders’ equity was about $5.1 million.

How did HeartCore’s Adjusted EBITDA change in 2026?

HeartCore’s Q2 2026 Adjusted EBITDA was $(1.3) million, down from $(0.1) million a year earlier. According to the company, first-half 2026 Adjusted EBITDA was $(2.9) million versus $(1.2) million in 2025, as operational performance weakened.

Is HeartCore (HTCR) currently in compliance with Nasdaq listing requirements?

HeartCore has regained compliance with Nasdaq’s $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). According to the company, this restores adherence to a key listing standard for its common shares on the Nasdaq Capital Market.